Revium Rx (RVRC) Cash & Current Investments (2024 - 2026)

Revium Rx has disclosed Cash & Current Investments across 3 years of filings, most recently posting $1.5 million for Q2 2026.

• In Q2 2026, Cash & Current Investments changed N/A year-over-year to $1.5 million; the TTM figure through Jun 2026 stood at $1.5 million (changed N/A YoY), while the FY2025 annual figure was $2.7 million, down 48.65% from the prior year.
• Cash & Current Investments came in at $1.5 million for Q2 2026 at Revium Rx, down from $2.7 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $5.3 million in Q4 2024 to a low of $1.5 million in Q2 2026.
• Average Cash & Current Investments over 3 years is $3.2 million, with a median of $2.7 million recorded in 2025.
• The largest YoY upside for Cash & Current Investments was 48.65% in 2025 against a maximum downside of 48.65% in 2025.
• Over 3 years, Cash & Current Investments stood at $5.3 million in 2024, then tumbled by 48.65% to $2.7 million in 2025, then plunged by 44.45% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $1.5 million in Q2 2026, $2.7 million in Q4 2025, and $5.3 million in Q4 2024.